blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP4034107

EP4034107 - JAK INHIBITORS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  27.06.2024
Database last updated on 03.10.2024
FormerRequest for examination was made
Status updated on  01.07.2022
FormerThe international publication has been made
Status updated on  03.04.2021
Most recent event   Tooltip27.06.2024Application deemed to be withdrawnpublished on 31.07.2024  [2024/31]
Applicant(s)For all designated states
Vimalan Biosciences, Inc.
662 Encinitas Blvd., Suite 250
Encinitas, CA 92024 / US
[2022/31]
Inventor(s)01 / MOHAN, Raju
662 Encinitas Blvd. Suite 250
Encinitas, California 92024 / US
02 / NUSS, John
662 Encinitas Blvd. Suite 250
Encinitas, California 92024 / US
03 / HARRIS, Jason
662 Encinitas Blvd. Suite 250
Encinitas, California 92024 / US
04 / YUAN, Shendong
662 Encinitas Blvd. Suite 250
Encinitas, California 92024 / US
 [2022/31]
Representative(s)Mewburn Ellis LLP
Aurora Building
Counterslip
Bristol BS1 6BX / GB
[2022/31]
Application number, filing date20868450.624.09.2020
[2022/31]
WO2020US52556
Priority number, dateUS201962905958P25.09.2019         Original published format: US 201962905958 P
[2022/31]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2021062036
Date:01.04.2021
Language:EN
[2021/13]
Type: A1 Application with search report 
No.:EP4034107
Date:03.08.2022
Language:EN
The application published by WIPO in one of the EPO official languages on 01.04.2021 takes the place of the publication of the European patent application.
[2022/31]
Search report(s)International search report - published on:US01.04.2021
(Supplementary) European search report - dispatched on:EP01.08.2023
ClassificationIPC:C07D487/04, A61P37/00, A61K31/4155
[2023/35]
CPC:
C07D487/04 (EP,IL,US); A61P37/00 (EP)
Former IPC [2022/31]A61K31/4155, C07D403/14, C07D487/04
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/31]
TitleGerman:JAK-INHIBITOREN[2022/31]
English:JAK INHIBITORS[2022/31]
French:INHIBITEURS DE JAK[2022/31]
Entry into regional phase05.04.2022National basic fee paid 
05.04.2022Search fee paid 
05.04.2022Designation fee(s) paid 
05.04.2022Examination fee paid 
Examination procedure05.04.2022Examination requested  [2022/31]
09.11.2022Amendment by applicant (claims and/or description)
01.03.2024Application deemed to be withdrawn, date of legal effect  [2024/31]
22.03.2024Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2024/31]
Fees paidRenewal fee
27.09.2022Renewal fee patent year 03
Penalty fee
Additional fee for renewal fee
30.09.202304   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[IA]WO2012143320  (CELLZOME LTD [GB], et al) [I] 1-5,7-10,12-14 * claim 1 * * page 58, lines 19-20 * [A] 6,11;
 [A]CN108864057  (UNIV SHANDONG) [A] 1-14* claim 1; compound III *
International search[A]US2012207763  (BRAIN CHRISTOPHER THOMAS [US], et al) [A] 1 * entire document *;
 [A]WO2012143320  (CELLZOME LTD [GB], et al) [A] 1 * entire document *;
 [A]US8580802  (SALITURO FRANCESCO [US], et al) [A] 1 * entire document *;
 [A]US9642855  (GALATSIS PAUL [US], et al) [A] 1* entire document *
 [A]  - Anonymous, PUBCHEM SUBSTANCE, (20170804), Database accession no. SID 340331023, URL: NCBI [A] 1 * entire document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.